GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Z

Zimmer Biomet Holdings ZBH · USD

Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States

S&P 500

Compare

101.47

-1.79%

Close of 19 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Zimmer Biomet Holdings — daily ZBH Delayed
Market value
$19.63bn
Last close × shares
Volume
1.8m
Shares, 19 Nov 2026
Price to earnings
31.0
Dividend yield
0.87%

About Zimmer Biomet Holdings

From its filings with the US Securities and Exchange Commission

SEC filings

Zimmer Biomet Holdings is based in Warsaw, Indiana and is incorporated in Delaware. Its shares trade on NYSE under the ticker ZBH. It is a member of the S&P 500. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $8.23bn and net income of $705.1m. At that date it held total assets of $23.09bn and shareholders' equity of $12.70bn. By business, Knees. brought in 40.4% of revenue, followed by SET. at 26.1% and Hips. at 25.4%. By region, United States [Member] accounted for 57.9%, followed by Non-US [Member] at 42.1%.

In its own words

Zimmer Biomet Holdings was incorporated in Delaware in 2001. Our history dates to 1927, when Zimmer Manufacturing Company, a predecessor, was founded in Warsaw, Indiana. On August 6, 2001, we were spun off from our former parent and became an independent public company. In 2015, we acquired LVB Acquisition, Inc. (“LVB”), the parent company of Biomet, Inc. (“Biomet”), and LVB and Biomet became our wholly-owned subsidiaries. In connection with the merger, we changed our name from Zimmer Holdings, Inc. to Zimmer Biomet Holdings, Inc.

Our primary customers include orthopedic surgeons, neurosurgeons, and other specialists, healthcare institutions, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent clinicians.

We market and sell products through two principal channels: 1) direct to healthcare institutions, such as hospitals and ambulatory surgery centers, referred to as direct channel accounts; and 2) through stocking distributors and healthcare dealers. With direct channel accounts and some healthcare dealers, inventory is generally consigned to sales agents or customers. With sales to stocking distributors, some healthcare dealers and some hospitals, and at times to some direct channel accounts, title to product typically passes upon shipment. Consignment sales represented approximately 85 percent of our net sales in 2025. No individual customer accounted for more than 2 percent of our net sales for 2025.

Quoted from its 10-K, filed 20 Feb 2026. Read the filing on SEC.gov ↗

More about Zimmer Biomet Holdings →

How it makes its money

Revenue, year to 31 Dec 2025

  • Knees. $3.32bn · 40.4%
  • SET. $2.15bn · 26.1%
  • Hips. $2.09bn · 25.4%
  • Technology And Data, Bone Cement and Surgical [Member] $665.6m · 8.1%

Latest on Zimmer Biomet Holdings

Our reporting

Next results

9 Feb 2027

Due on 9 Feb 2027. Analysts expect earnings of 2.49 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Zimmer Biomet Holdings's ticker?

Zimmer Biomet Holdings trades as ZBH on its US listing, under ISIN US98956P1021.

What was Zimmer Biomet Holdings's last closing price?

101.47 on 19 Nov 2026. The figure is in USD and is never converted.

When does Zimmer Biomet Holdings next report results?

Results are expected on 9 Feb 2027, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
SEC filings and our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.